Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Treasury Shares (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Treasury Shares for 4 consecutive years, with $364594.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Treasury Shares rose 261.41% year-over-year to $364594.0, compared with a TTM value of $364594.0 through Sep 2023, up 261.41%, and an annual FY2022 reading of $128280.0, changed N/A over the prior year.
  • Treasury Shares was $364594.0 for Q3 2023 at Terns Pharmaceuticals, down from $372301.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $388103.0 in Q1 2023 and bottomed at $71429.0 in Q1 2021.
  • Average Treasury Shares over 4 years is $186786.8, with a median of $100880.0 recorded in 2022.
  • The sharpest move saw Treasury Shares increased 4.76% in 2022, then soared 418.65% in 2023.
  • Year by year, Treasury Shares stood at $83334.0 in 2020, then dropped by 14.29% to $71429.0 in 2021, then surged by 79.59% to $128280.0 in 2022, then skyrocketed by 184.22% to $364594.0 in 2023.
  • Business Quant data shows Treasury Shares for TERN at $364594.0 in Q3 2023, $372301.0 in Q2 2023, and $388103.0 in Q1 2023.